Christopher L. Gaenzle, EVP, CAO & General Counsel at PRA Health Sciences, Inc. (PRAH), sold 53,002 shares at $168.06 ($8.9M) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $8.9M PRAH by EVP, CAO & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.40 | 1,300 | $218K | 2.4% |
| 2 | $168.06 | 13,391 | $2.3M | 25.2% |
| 3 | $168.06 | 13,391 | $2.3M | 25.2% |
| 4 | $169.41 | 12,114 | $2.1M | 23.0% |
| 5 | $169.41 | 12,114 | $2.1M | 23.0% |
| 6 | $169.75 | 692 |
| $117K |
| 1.3% |
| Total | $168.68 avg | 53,002 | $8.9M | 100% |
| Filing → |
| PRAH | SELL | 2021-01-11 | $816K | — | Filing → |
| PRAH | SELL | 2020-08-17 | $281K | — | Filing → |
| SYNH | SELL | 2018-01-23 | $60K | — | Filing → |